Early Clinical Results of a Novel Anti-CD20 Chimeric Antigen Receptor (CAR)-T Cell Therapy for B-Cell NHL Patients Who Are Relapsed/Resistant Following CD19 CAR-T Therapy

被引：4
|
作者：
Ye, Shiguang
Huang, Jiaqi
Zhu, Shigui
Yao, Xin
Zhou, Lili
Zhu, Judy
Zheng, Chengxiao
Chen, Shiyi
Lan, Liping
Chen, Shicheng
Wei, Yutian
Shu, Wangqin
Ye, Chen
Zhang, Dan
Wang, Rirfei
Hong, Yi
Ren, Jiaqiang
Zhang, Li
Zhang, Wenjun
Tang, Xiaochen
Wang, Junbang
Liu, Jie
Humphries, Michael
Li, Ping
Yao, Yihong
Liang, Aibin
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-138538
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Comorbidities Associated with Early Mortality after CD19 CAR-T Cell Therapy
    Tang, Kevin
    Khwaja, Raamis
    Feng, Lei
    Strati, Paolo
    Steiner, Raphael E.
    Nair, Ranjit
    Flowers, Christopher R.
    Saini, Neeraj
    Ramdial, Jeremy L.
    Srour, Samer A.
    Champlin, Richard E.
    Rondon, Gabriela
    Torres, Janet
    Kebriaei, Partow
    Nastoupil, Loretta J.
    Mistry, Haleigh
    Shpall, Elizabeth J.
    Nieto, Yago
    Westin, Jason
    Neelapu, Sattva S.
    Ahmed, Sairah
    BLOOD, 2022, 140 : 4684 - 4685
  • [22] Chimeric Antigen Receptor (CAR) T Cells Targeting the CD19 Antigen for the Treatment of Pediatric Relapsed B Cell ALL
    Curran, Kevin J.
    Riviere, Isabelle
    Kobos, Rachel
    Kernan, Nancy A.
    Boulad, Farid
    Prockop, Susan E.
    Scaradavou, Andromachi
    Renaud, Thomas M.
    Shukla, Neerav
    Steinherz, Peter G.
    Park, Jae H.
    Sauter, Craig S.
    O'Reilly, Richard J.
    Sadelain, Michel
    Brentjens, Renier J.
    BLOOD, 2014, 124 (21)
  • [23] TP53 and CD19-Directed Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Large B-Cell Lymphoma
    Shouval, Roni
    Tomas, Ana Alarcon
    Fein, Joshua A.
    Flynn, Jessica
    Markovits, Ettai
    Mayer, Shimrit
    Afuye, Aishat Olaide
    Alperovich, Anna
    Anagnostou, Theodora
    Batlevi, Connie Lee
    Dahi, Parastoo B.
    Devlin, Sean M.
    Fingrut, Warren
    Giralt, Sergio A.
    Lin, Richard J.
    Salles, Gilles
    Sauter, Craig S.
    Scordo, Michael
    Shah, Gunjan L.
    Shah, Nishi
    Shouval, Ruth Scherz
    van den Brink, Marcel
    Perales, Miguel-Angel
    Palomba, Maria Lia
    BLOOD, 2021, 138
  • [24] Sequential anti-CD19, anti-CD22, and anti-CD20 autologous chimeric antigen receptor T cell (CAR-T) therapies treating a child with relapsed refractory Burkitt lymphoma
    Du, Juan
    Zhang, Yonghong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [25] Rapid identification of early infections in febrile patients after CD19 target CAR-T cell therapy for B-cell malignancies
    Pu, Lian-Fang
    Zheng, Hui-Min
    Feng, Xiang-Jiang
    Charwudzi, Alice
    Liang, Xue
    Hu, Lin-Hui
    Ding, Yang-Yang
    Liu, Ze-Lin
    Liao, Ya
    Xiong, Shu-Dao
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [26] Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation
    Liu, Shuangyou
    Deng, Biping
    Yin, Zhichao
    Lin, Yuehui
    An, Lihong
    Liu, Dan
    Pan, Jing
    Yu, Xinjian
    Chen, Bingzhen
    Wu, Tong
    Chang, Alex H.
    Tong, Chunrong
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (06) : 671 - 679
  • [27] Axicabtagene Ciloleucel CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real-World Experience
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (05) : 9 - 10
  • [28] Dynamics of Radiomic Features Following Bridging Therapy Determine CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy Outcome
    Hubbeling, Harper
    Leithner, Doris
    Silverman, Emily A.
    Flynn, Jessica R.
    Devlin, Sean M.
    Shah, Gunjan L.
    Fregonese, Beatrice
    Bedmutha, Akshay
    Wills, Beatriz
    Tomas, Ana Alarcon
    Parascondola, Allison
    Saldia, Amethyst
    Landego, Ivan
    Dahi, Parastoo B.
    Giralt, Sergio A.
    Lin, Richard J.
    Scordo, Michael
    Salles, Gilles
    Yahalom, Joachim
    Palomba, Maria Lia
    Schoder, Heiko
    Perales, Miguel-Angel
    Shouval, Roni
    Imber, Brandon S.
    BLOOD, 2023, 142
  • [29] Improvement in Radiomic Features Following Bridging Therapy is Prognostic for CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy Outcome
    Hubbeling, H. G.
    Leithner, D.
    Silverman, E. A.
    Flynn, J.
    Devlin, S.
    Shah, G. L.
    Fregonese, B.
    Bedmutha, A.
    Boardman, A.
    Dal, P. B.
    Lin, R. J.
    Park, J. H.
    Scordo, M.
    Salles, G.
    Yahalom, J.
    Palomba, M. L.
    Schoder, H.
    Perales, M. A.
    Shouval, R.
    Imber, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S66 - S66
  • [30] CD19 CAR-T Cell Therapy: High Efficacy in Autoimmune Diseases
    Brudermanns, Britta
    TRANSFUSIONSMEDIZIN, 2024, 14 (03) : 126 - 126
12345